Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and immunogenicity of LBVC Sabin inactivated poliomyelitis vaccine vs Imovax Polio in healthy infants
TCTR20161210001Phase 3Not yet recruiting
- Sponsor
- LG Chem
- Start
- May 2017
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of inactivated poliovirus vaccine in poliomyelitis, sponsored by LG Chem. Planned start May 2017; status: not yet recruiting.
02
Drugs
inactivated poliovirus vaccine
03
Conditions
poliomyelitis
Beyond the preview
Go deeper on TCTR20161210001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20161210001.